Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback